Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid lipid nanoparticles for parenteral drug delivery.

S A Wissing1, O Kayser, R H Müller

  • 1DDS, Drug Delivery Services, GmbH, Kronskamp 11, 24119 Kronshagen, Germany.

Advanced Drug Delivery Reviews
|April 28, 2004
PubMed
Summary

This review covers solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid drug conjugates (LDC) for parenteral drug delivery. It details their production, stability, drug incorporation, and biological/biopharmaceutical aspects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of nanocrystal size on the in vivo absorption kinetics of caffeine after topical application.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2021
Same author

Maximum Loaded Amorphous Azithromycin Produced Using the Wetness Impregnation Method with Fractional Steps for Dermal Prophylaxis Against Lyme Disease.

Die Pharmazie·2019
Same author

Azithromycin nanocrystals for dermal prevention of tick bite infections.

Die Pharmazie·2019
Same author

Liposomes, lipid nanocapsules and smartCrystals®: A comparative study for an effective quercetin delivery to the skin.

International journal of pharmaceutics·2018
Same author

smartLipids<sup>®</sup> as third solid lipid nanoparticle generation - stabilization of retinol for dermal application.

Die Pharmazie·2018
Same author

Quercetin topical application, from conventional dosage forms to nanodosage forms.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2016

Area of Science:

  • Pharmaceutical Nanotechnology
  • Drug Delivery Systems
  • Biomaterials Science

Background:

  • Solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid drug conjugates (LDC) are advanced lipid-based nanoparticle systems.
  • These nanoparticles offer potential for parenteral drug administration, improving drug efficacy and safety.

Purpose of the Study:

  • To provide a comprehensive overview of lipid-based nanoparticles for parenteral drug delivery.
  • To discuss the structural characteristics, production methods, stability, and drug incorporation mechanisms of SLN, NLC, and LDC.
  • To review the biological activity, pharmacokinetics, and toxicity of parenterally administered SLN.

Main Methods:

  • Literature review of scientific articles and research papers on lipid-based nanoparticles.

Related Experiment Videos

  • Comparative analysis of different types of lipid nanoparticles (SLN, NLC, LDC).
  • Discussion of manufacturing techniques, scalability, stability studies, and drug loading efficiencies.

    • Main Results:

    • Detailed description of the structural differences between SLN, NLC, and LDC.
    • Overview of various production methods, highlighting scalability for industrial application.
    • Discussion on critical factors affecting nanoparticle stability and drug encapsulation efficiency.
    • Summary of in vivo studies on the biological activity and pharmacokinetic profiles of parenteral SLN.
    • Review of toxicological data associated with lipid-based nanoparticles.

    Conclusions:

    • Lipid-based nanoparticles, including SLN, NLC, and LDC, represent a promising platform for parenteral drug delivery.
    • Understanding their production, stability, and drug incorporation is crucial for successful formulation development.
    • Parenteral administration of SLN shows potential for favorable pharmacokinetic profiles and manageable toxicity, warranting further investigation.